TUCSON, Ariz., July 22, 2025 — Stakeholders across the life sciences ecosystem are invited to attend the 2025 Critical Path Institute® (C-Path) Global Impact Conference (CGIC), taking place Sept. 9–11 ...
TUCSON, Ariz., June 18, 2025 — Critical Path Institute’s® (C-Path) Translational Therapeutics Accelerator (TRxA) proudly announced today a $250,000 grant award aimed at developing a novel treatment ...
Digital pathology and artificial intelligence are transforming the drug development landscape, accelerating the path to ...
The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...
Accelerated drug development expertise. For small startups and academic spinoffs bringing their first molecules to market, ...
Zacks Small Cap Research on MSN
ASBP: A platform approach to drug delivery with an unconventional path to commercialization
By David Bautz, PhD NASDAQ: ASBP Aspire Biopharma Holdings, Inc. (NASDAQ: ASBP) is attempting something relatively uncommon ...
Discover how quality-driven drug development and AI accelerate safer medicines, reduce risk, and improve patient outcomes.
Formulation development serves as a vital bridge between a drug substance and a drug product that will remain stable and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results